Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yemin Wang

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Elife|December 23, 2020
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanismKrystal Ann Orlando, Amber K Douglas, Aierken Abudu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Nature Communications|May 20, 2023
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-lossXianbing Zhu, Zheng Fu, Shary Y Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase InhibitionJessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
The Journal of Pathology|May 15, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progressionAmal M El-Naggar, Yuqin Li, Busra Turgu, et al.
Cancer Research|May 14, 2025
SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancerXianbing Zhu, Zheng Fu, Giulio Aceto, et al.
Nature Genetics|January 9, 2023
Single-cell transcriptomic analysis of endometriosisMarcos A S Fonseca, Marcela Haro, Kelly N Wright, et al.
Cancer Research|May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
EMBO Reports|November 1, 2019
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasisAmal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, et al.
Elife|December 23, 2020
Re-expression of SMARCA4/BRG1 in small cell carcinoma of ovary, hypercalcemic type (SCCOHT) promotes an epithelial-like gene signature through an AP-1-dependent mechanismKrystal Ann Orlando, Amber K Douglas, Aierken Abudu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Nature Communications|May 20, 2023
Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-lossXianbing Zhu, Zheng Fu, Shary Y Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2018
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase InhibitionJessica D Lang, William P D Hendricks, Krystal A Orlando, et al.
The Journal of Pathology|May 15, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progressionAmal M El-Naggar, Yuqin Li, Busra Turgu, et al.
Cancer Research|May 14, 2025
SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancerXianbing Zhu, Zheng Fu, Giulio Aceto, et al.
Nature Genetics|January 9, 2023
Single-cell transcriptomic analysis of endometriosisMarcos A S Fonseca, Marcela Haro, Kelly N Wright, et al.
Cancer Research|May 23, 2025
Loss of SMARCA4 Leads to Intron Retention and Generation of Tumor-Associated Antigens in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeElizabeth A Raupach, Apurva M Hegde, Krystine Garcia-Mansfield, et al.
Pageof 9